<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04848961</url>
  </required_header>
  <id_info>
    <org_study_id>21-103</org_study_id>
    <nct_id>NCT04848961</nct_id>
  </id_info>
  <brief_title>A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer</brief_title>
  <official_title>Leveraging Mammography to Identify and Engage Women at Risk for Lung Cancer in Lung Cancer Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a digital strategy to increase awareness about lung&#xD;
      cancer screening among women who are eligible to receive it. The digital strategy involves&#xD;
      email communications and LungTalk, a web-based (accessed through the Internet) health&#xD;
      communication tool that uses text, audio, video, and animation to increase awareness and&#xD;
      knowledge about lung cancer screening. This study will focus on women who have recently&#xD;
      received a screening mammogram.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2021</start_date>
  <completion_date type="Anticipated">April 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 9, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening</measure>
    <time_frame>6 months</time_frame>
    <description>Develop a proactive digital outreach and engagement strategy to identify breast screening patients who are eligible for lung screening.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>Women who have had a mammogram</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consist of eligible women who have had a mammogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LungTalk</intervention_name>
    <description>MSK developed LungTalk, a novel computer-tailored health communication and decision support tool to (1) increase awareness and knowledge about lung screening; (2) decrease perceived barriers to screening based upon misinformation; and (3) increase screening rates.</description>
    <arm_group_label>Women who have had a mammogram</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  LDCT screening-eligible women who received a BiRADS 1 (negative) or 2&#xD;
             (benign/non-cancerous finding) result from a screening mammogram in the last 7 days&#xD;
&#xD;
          -  Age 50-80 years&#xD;
&#xD;
          -  ≥ 20-pack-year smoking history of combustible cigarettes as per self report&#xD;
&#xD;
          -  Women who currently smoke or quit within past 15 years as per self report&#xD;
&#xD;
          -  Lung screening naïve as per self-report&#xD;
&#xD;
          -  Has a working email and internet access as per self-report&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lung cancer diagnosis&#xD;
&#xD;
          -  Chest CT within the last 12 months&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Carter-Harris, PhD, NP, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa Carter-Harris, PhD, NP, RN</last_name>
    <phone>646-888-0040</phone>
    <email>carterl@mskcc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tali Amir, MD</last_name>
    <phone>201-775-7153</phone>
    <email>amirt@mskcc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hartford Healthcare Cancer Institute @ Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Salner, MD</last_name>
      <phone>860-972-2803</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities)</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD,NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Monmouth (Limited Protocol Activities)</name>
      <address>
        <city>Middletown</city>
        <state>New Jersey</state>
        <zip>07748</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD,NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Bergen (Limited Protocol Activities)</name>
      <address>
        <city>Montvale</city>
        <state>New Jersey</state>
        <zip>07645</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD,NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)</name>
      <address>
        <city>Commack</city>
        <state>New York</state>
        <zip>11725</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD,NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memoral Sloan Kettering Westchester (Limited Protocol Activities)</name>
      <address>
        <city>Harrison</city>
        <state>New York</state>
        <zip>10604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD,NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD, NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
    <contact_backup>
      <last_name>E.</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Nassau (Limited Protocol Activities)</name>
      <address>
        <city>Uniondale</city>
        <state>New York</state>
        <zip>11553</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Carter-Harris, PhD,NP, RN</last_name>
      <phone>646-888-0040</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 9, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mammogram</keyword>
  <keyword>LDCT screening</keyword>
  <keyword>BiRADS 1</keyword>
  <keyword>BiRADS 2</keyword>
  <keyword>21-103</keyword>
  <keyword>Memorial Sloan Kettering Cancer Center</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

